Ur life is a journey of learning to love urself first, and then extending that love to others in every encounter
seen from China

seen from India

seen from United States
seen from Yemen
seen from Türkiye
seen from United Kingdom

seen from United States

seen from United States
seen from China

seen from United Kingdom
seen from India
seen from United Kingdom
seen from United States
seen from China

seen from United States
seen from Germany
seen from United States

seen from Canada
seen from United States
seen from China
Ur life is a journey of learning to love urself first, and then extending that love to others in every encounter
Growing number of chemicals linked with brain disorders in children
Toxic chemicals may be triggering the recent increases in neurodevelopmental disabilities among children -- such as autism, attention-deficit hyperactivity disorder, and dyslexia -- according to a new study from Harvard School of Public Health (HSPH) and Icahn School of Medicine at Mount Sinai. The researchers say a new global prevention strategy to control the use of these substances is urgently needed.
"The greatest concern is the large numbers of children who are affected by toxic damage to brain development in the absence of a formal diagnosis. They suffer reduced attention span, delayed development, and poor school performance. Industrial chemicals are now emerging as likely causes," said Philippe Grandjean.
Philippe Grandjean, Philip Landrigan. Neurobehavioural effects of developmental toxicity. Lancet Neurology, February 2014 DOI: 10.1016/S1474-4422(13)70278-3
The Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey (NHANES) includes prevalence data for children ages 8 to 15; a slightly younger age range than the data from the NCS-A chart above. These data show that approximately 13 percent of children ages 8 to 15 had a diagnosable mental disorder within the previous year. The most common disorder among this age group is attention-deficit/hyperactivity disorder (ADHD), which affects 8.5 percent of this population. This is followed by mood disorders broadly at 3.7 percent, and major depressive disorder specifically at 2.7 percent.